DNAprint Genomics (DNAG)

[mikenickels]

mjam - that's my question
The original business model involved partnering with major pharmas and/or medical groups to match patients and drugs based genetic predisposition.
A drug company by definition, would make new drugs. Perhpas we are talking about altering established drugs to bypass genetic problems, I don't know. I also don't know how that would bypass the FDA.
So frankly, I am not sure what Dr. Frudakis meant. I am not implying that he had nothing in mind. I would just like to undestand it.